Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma

World Journal of Clinical Oncology

Volumn 5, Issue 2, 2014, Pages 142-148

  Larson, Erik W ^a,b,c   Peterson, Halloran E ^a,b,c   Lamoreaux, Wayne T ^a,b   MacKay, Alexander R ^a,d   Fairbanks, Robert K ^a,b   Call, Jason A ^a,b   Carlson, Jonathan D ^a,e   Ling, Benjamin C ^e   Demakas, John J ^a,f   Cooke, Barton S ^a   Lee, Christopher M ^a,b  

^a Gamma Knife of Spokane   (United States)

^b Cancer Care Northwest   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Mackay and Meyer MDs   (United States)

^e Inland Neuroscience and Spine Center   (United States)

^f Spokane Brain and Spine   (United States)

Author keywords

Gamma Knife radiosurgery; Glioblastoma; Malignant glioma; Multimodal treatment; Salvage therapy; Stereotactic radiosurgery

Indexed keywords

EID: 84915763304     PISSN: None     EISSN: 22184333     Source Type: Journal    
DOI: 10.5306/wjco.v5.i2.142     Document Type: Review

References (29)

1. Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer Genet 2012; 205: 613-621 [PMID: 23238284 DOI: 10.1016/j.cancergen.2012.10.009]
2. Hou LC, Veeravagu A, Hsu AR, Tse VC. Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus 2006; 20: E5 [PMID: 16709036 DOI: 10.3171/foc.2006.20.4.2]
3. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G. Long-term survival with glioblastoma multiforme. Brain 2007; 130: 2596-2606 [PMID: 17785346 DOI: 10.1093/brain/awm204]
4. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol 2009; 10: 459-466 [PMID: 19269895 DOI: 10.1016/S1470-2045(09)70025-7]
5. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993; 85: 704-710 [PMID: 8478956 DOI: 10.1093/jnci/85.9.704]
6. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, Fischbach AJ, Curran WJ. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 1998; 40: 51-55 [PMID: 9422557 DOI: 10.1016/S0360-3016(97)00485-9]
7. Li J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ, Mehta MP. Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys 2011; 81: 623-630 [PMID: 20888136 DOI: 10.1016/j.ijrobp.2010.06.012]
8. Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier A, Lacombe D, Stupp R. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol 2008; 9: 29-38 [PMID: 18082451 DOI: 10.1016/S1470-2045(07)70384-4]
9. Skeie BS, Enger PØ, Brøgger J, Ganz JC, Thorsen F, Heggdal JI, Pedersen PH. yγ knife surgery versus reoperation for recurrent glioblastoma multiforme. World Neurosurg 2012; 78: 658-669 [PMID: 22484078 DOI: 10.1016/j.wneu.2012.03.024]
10. Park KJ, Kano H, Iyer A, Liu X, Niranjan A, Flickinger JC, Lieberman FS, Lunsford LD, Kondziolka D. Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study. J Neurooncol 2012; 107: 323-33 [PMID: 22057917 DOI: 10.1007/s11060-011-0744-9]
11. Elliott RE, Parker EC, Rush SC, Kalhorn SP, Moshel YA, Narayana A, Donahue B, Golfinos JG. Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection. World Neurosurg 2011; 76: 128-140; discussion 61-62 [PMID: 21839964 DOI: 10.1016/j.wneu.2010.12.053]
12. Silbergeld DL, Chicoine MR. Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 1997; 86: 525-531 [PMID: 9046311 DOI: 10.3171/jns.1997.86.3.0525]
13. Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ Jr. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 2004; 60: 853-860 [PMID: 15465203 DOI: 10.1016/j.ijrobp.2004.04.011]
14. Tatter SB. Recurrent malignant glioma in adults. Curr Treat Options Oncol 2002; 3: 509-524 [PMID: 12392640 DOI: 10.1007/s11864-002-0070-8]
15. Griffiths A, Marinovich L, Barton MB, Lord SJ. Cost analysis of Gamma Knife stereotactic radiosurgery. Int J Technol Assess Health Care 2007; 23: 488-494 [PMID: 17937838 DOI: 10.1017/S0266462307070584]
16. Blamek S, Grzadziel A, Miszczyk L. Robotic radiosurgery vs micro-multileaf collimator: a dosimetric comparison for large or critically located arteriovenous malformations. Radiat Oncol 2013; 8: 205 [PMID: 23968165 DOI: 10.1186/1748-717X-8-205]
17. Stieber VW, Bourland JD, Tome WA, Mehta MP. Gentlemen (and ladies), choose your weapons: Gamma knife vs. linear accelerator radiosurgery. Technol Cancer Res Treat 2003; 2: 79-86 [PMID: 12680787]
18. Plowman PN, Doughty D. Stereotactic radiosurgery, X: clinical isodosimetry of gamma knife versus linear accelerator X-knife for pituitary and acoustic tumours. Clin Oncol (R Coll Radiol) 1999; 11: 321-329 [PMID: 10591820 DOI: 10.1053/clon.1999.9074]
19. Dutta D, Balaji Subramanian S, Murli V, Sudahar H, Gopalakrishna Kurup PG, Potharaju M. Dosimetric comparison of Linac-based (BrainLAB®) and robotic radiosurgery (CyberKnife ®) stereotactic system plans for acoustic schwannoma. J Neurooncol 2012; 106: 637-642 [PMID: 21892741 DOI: 10.1007/s11060-011-0703-5]
20. Perks JR, St George EJ, El Hamri K, Blackburn P, Plowman PN. Stereotactic radiosurgery XVI: Isodosimetric comparison of photon stereotactic radiosurgery techniques (gamma knife vs. micromultileaf collimator linear accelerator) for acoustic neuroma-and potential clinical importance. Int J Radiat Oncol Biol Phys 2003; 57: 1450-1459 [PMID: 14630285]
21. Kida Y, Yoshimoto M, Hasegawa T. Radiosurgery for intracranial gliomas. Prog Neurol Surg 2009; 22: 122-128 [PMID: 18948724 DOI: 10.1159/000163387]
22. Kohshi K, Yamamoto H, Nakahara A, Katoh T, Takagi M. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas. J Neurooncol 2007; 82: 297-303 [PMID: 17120158 DOI: 10.1007/s11060-006-9283-1]
23. Kong DS, Lee JI, Park K, Kim JH, Lim DH, Nam DH. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas. Cancer 2008; 112: 2046-2051 [PMID: 18338759 DOI: 10.1002/cncr.23402]
24. Hsieh PC, Chandler JP, Bhangoo S, Panagiotopoulos K, Kalapurakal JA, Marymont MH, Cozzens JW, Levy RM, Salehi S. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 2005; 57: 684-692; discussion 684-692 [PMID: 16239880 DOI: 10.1227/01.NEU.0000175550.96901.A3]
25. Pouratian N, Crowley RW, Sherman JH, Jagannathan J, Sheehan JP. Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma. J Neurooncol 2009; 94: 409-418 [PMID: 19330482 DOI: 10.1007/s11060-009-9873-9]
26. Larson EW, Peterson HE, Fairbanks RK, Lamoreaux WT, Mackay AR, Call JA, Demakas JJ, Cooke BS, Lee CM. Long- Term Survival and Improved Quality of Life following Multiple Repeat Gamma Knife Radiosurgeries for Recurrent Glioblastoma Multiforme: A Case Report and Review of the Literature. Case Rep Oncol Med 2013; 2013: 431857 [PMID: 24175106 DOI: 10.1155/2013/431857]
27. Thumma SR, Elaimy AL, Daines N, Mackay AR, Lamoreaux WT, Fairbanks RK, Demakas JJ, Cooke BS, Lee CM. Longterm survival after gamma knife radiosurgery in a case of recurrent glioblastoma multiforme: a case report and review of the literature. Case Rep Med 2012; 2012: 545492 [PMID: 22548078 DOI: 10.1155/2012/545492]
28. Koga T, Maruyama K, Tanaka M, Ino Y, Saito N, Nakagawa K, Shibahara J, Todo T. Extended field stereotactic radiosurgery for recurrent glioblastoma. Cancer 2012; 118: 4193-4200 [PMID: 22180028 DOI: 10.1002/cncr.27372]
29. Cerniglia GJ, Karar J, Tyagi S, Christofidou-Solomidou M, Rengan R, Koumenis C, Maity A. Inhibition of autophagy as a strategy to augment radiosensitization by the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. Mol Pharmacol 2012; 82: 1230-1240 [PMID: 22989521 DOI: 10.1124/mol.112.080408]